Reviva Pharmaceuticals raises $3.8M net in public offering of common stock and warrants

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Net proceeds from offering updated to $3.8M; closed Aug 22, 2024.
Sold 3,276,262 shares at $1.05/share along with warrants to purchase up to 4,761,905 shares at $0.7964.
Also issued pre-funded warrants for 1,485,643 shares and underwriter warrants for 238,095 shares at $1.3125.
Existing warrants from 2021 and 2023 amended: exercise price lowered to $0.7964, expiration extended to 5 years.
Titan Partners Group underwriter; 8.0% commission and expense reimbursement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.